New COPD drug candidate AN01 begins first human safety tests
Knowledge-focused
Recruiting now
This early-stage study is testing a new inhaled medicine called AN01 in 24 healthy adults. The goal is to check if it is safe and how the body processes it. This study does not aim to treat any disease; it is a first step to see if the drug is safe enough to test in people with C…
Phase: PHASE1 • Sponsor: AirNexis Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC